FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979323925> ?p ?o ?g. }

• W1979323925 endingPage "e37133" @default.
• W1979323925 startingPage "e37133" @default.
• W1979323925 abstract "Earlier observations in the literature suggest that proteolytic degradation of excess unmatched α-globin chains reduces their accumulation and precipitation in β-thalassaemia erythroid precursor cells and have linked this proteolytic degradation to the activity of calpain protease. The aim of this study was to correlate the activity of calpain and its inhibitor, calpastatin, with different degrees of disease severity in β-thalassaemia. CD34+ cells were enriched from peripheral blood of healthy individuals (control group) and patients with mild and severe clinical presentations of β0-thalassaemia/Hb E disease. By ex vivo cultivation promoting erythroid cell differentiation for 7 days, proerythroblasts, were employed for the functional characterization of the calpain-calpastatin proteolytic system. In comparison to the control group, enzymatic activity and protein amounts of μ-calpain were found to be more than 3-fold increased in proerythroblasts from patients with mild clinical symptoms, whereas no significant difference was observed in patients with severe clinical symptoms. Furthermore, a 1.6-fold decrease of calpastatin activity and 3.2-fold accumulation of a 34 kDa calpain-mediated degradation product of calpastatin were observed in patients with mild clinical symptoms. The increased activity of calpain may be involved in the removal of excess α-globin chains contributing to a lower degree of disease severity in patients with mild clinical symptoms." @default.
• W1979323925 created "2016-06-24" @default.
• W1979323925 creator A5017573285 @default.
• W1979323925 creator A5030649539 @default.
• W1979323925 creator A5055337483 @default.
• W1979323925 creator A5058246878 @default.
• W1979323925 creator A5058995760 @default.
• W1979323925 creator A5067331111 @default.
• W1979323925 creator A5070648467 @default.
• W1979323925 creator A5072213514 @default.
• W1979323925 creator A5085308198 @default.
• W1979323925 date "2012-05-16" @default.
• W1979323925 modified "2023-09-27" @default.
• W1979323925 title "Clinical Severity of β-thalassaemia/Hb E Disease Is Associated with Differential Activities of the Calpain-Calpastatin Proteolytic System" @default.
• W1979323925 cites W1569734298 @default.
• W1979323925 cites W1585589080 @default.
• W1979323925 cites W1604503695 @default.
• W1979323925 cites W1887446700 @default.
• W1979323925 cites W1952681831 @default.
• W1979323925 cites W1965079560 @default.
• W1979323925 cites W1969049846 @default.
• W1979323925 cites W1970996707 @default.
• W1979323925 cites W1971340527 @default.
• W1979323925 cites W1974643497 @default.
• W1979323925 cites W1987390807 @default.
• W1979323925 cites W1999284955 @default.
• W1979323925 cites W2002044194 @default.
• W1979323925 cites W2004355923 @default.
• W1979323925 cites W2005313237 @default.
• W1979323925 cites W2006823088 @default.
• W1979323925 cites W2009824045 @default.
• W1979323925 cites W2012801471 @default.
• W1979323925 cites W2015071589 @default.
• W1979323925 cites W2016459361 @default.
• W1979323925 cites W2017302540 @default.
• W1979323925 cites W2022364533 @default.
• W1979323925 cites W2026726965 @default.
• W1979323925 cites W2030569892 @default.
• W1979323925 cites W2042974419 @default.
• W1979323925 cites W2044802305 @default.
• W1979323925 cites W2045800171 @default.
• W1979323925 cites W2045881654 @default.
• W1979323925 cites W2052961424 @default.
• W1979323925 cites W2055309520 @default.
• W1979323925 cites W2065247148 @default.
• W1979323925 cites W2074458025 @default.
• W1979323925 cites W2092765483 @default.
• W1979323925 cites W2098507199 @default.
• W1979323925 cites W2169436026 @default.
• W1979323925 cites W2296111158 @default.
• W1979323925 cites W3111370454 @default.
• W1979323925 cites W327665178 @default.
• W1979323925 doi "https://doi.org/10.1371/journal.pone.0037133" @default.
• W1979323925 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3353910" @default.
• W1979323925 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22615919" @default.
• W1979323925 hasPublicationYear "2012" @default.
• W1979323925 type Work @default.
• W1979323925 sameAs 1979323925 @default.
• W1979323925 citedByCount "2" @default.
• W1979323925 countsByYear W19793239252014 @default.
• W1979323925 countsByYear W19793239252017 @default.
• W1979323925 crossrefType "journal-article" @default.
• W1979323925 hasAuthorship W1979323925A5017573285 @default.
• W1979323925 hasAuthorship W1979323925A5030649539 @default.
• W1979323925 hasAuthorship W1979323925A5055337483 @default.
• W1979323925 hasAuthorship W1979323925A5058246878 @default.
• W1979323925 hasAuthorship W1979323925A5058995760 @default.
• W1979323925 hasAuthorship W1979323925A5067331111 @default.
• W1979323925 hasAuthorship W1979323925A5070648467 @default.
• W1979323925 hasAuthorship W1979323925A5072213514 @default.
• W1979323925 hasAuthorship W1979323925A5085308198 @default.
• W1979323925 hasBestOaLocation W19793239251 @default.
• W1979323925 hasConcept C126322002 @default.
• W1979323925 hasConcept C134018914 @default.
• W1979323925 hasConcept C137061746 @default.
• W1979323925 hasConcept C181199279 @default.
• W1979323925 hasConcept C182220744 @default.
• W1979323925 hasConcept C202751555 @default.
• W1979323925 hasConcept C203014093 @default.
• W1979323925 hasConcept C2776714187 @default.
• W1979323925 hasConcept C2777488010 @default.
• W1979323925 hasConcept C2781307694 @default.
• W1979323925 hasConcept C3019223276 @default.
• W1979323925 hasConcept C55493867 @default.
• W1979323925 hasConcept C56928146 @default.
• W1979323925 hasConcept C71924100 @default.
• W1979323925 hasConcept C86803240 @default.
• W1979323925 hasConceptScore W1979323925C126322002 @default.
• W1979323925 hasConceptScore W1979323925C134018914 @default.
• W1979323925 hasConceptScore W1979323925C137061746 @default.
• W1979323925 hasConceptScore W1979323925C181199279 @default.
• W1979323925 hasConceptScore W1979323925C182220744 @default.
• W1979323925 hasConceptScore W1979323925C202751555 @default.
• W1979323925 hasConceptScore W1979323925C203014093 @default.
• W1979323925 hasConceptScore W1979323925C2776714187 @default.
• W1979323925 hasConceptScore W1979323925C2777488010 @default.
• W1979323925 hasConceptScore W1979323925C2781307694 @default.
• W1979323925 hasConceptScore W1979323925C3019223276 @default.

• next